Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Scancell Holdings Share News (SCLP)
SCLP Share
Price
SCLP Share
News
SCLP Share
Chat3
SCLP Share
Trades65
SCLP
Live RNS
SCLP Share
Charts
SCLP Level 2
Console
SCLP Live
Share Price
SCLP Broker
Ratings
SCLP Directors
Deals
SCLP Financial
Diary
SCLP
Fundamentals
SCLP Short
Positions
SCLP
Media
SCLP Company
Research
SCLP Company
Timeline
Scancell Holdings Information
Share Price Information for Scancell Holdings (SCLP)
Share Price is delayed by 15 minutes
Get Live Data
22.50
0.10 (0.44%)
Bid:
22.00
Ask:
23.00
Spread:
1.00 (4.545%)
Market Cap:
£234.54m
Last checked at -
Last checked at 
Intraday Scancell Holdings Share Chart
Scancell Holdings News
19 Feb 2021
IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
17 Feb 2021
IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares
IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares
3 Feb 2021
Scancell ends clinical development partnership with Cancer Research UK
(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on ...
3 Feb 2021
CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead
CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead
3 Feb 2021
AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win
AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win
3 Feb 2021
Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends
Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends
29 Jan 2021
IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine
IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine
21 Dec 2020
Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit
Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit
Follow the stocks
